John Spaid compensation by year
National Health Investors Summary Compensation Table · all 7 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Salary | $160,000 | $163,200 | $168,096 | $315,000 | $400,000 | $420,000 | $520,000 |
| Bonus | $40,000 | $100,000 | $80,000 | $375,000 | $54,272 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $0 | $197,200 | $173,280 | $476,710 |
| Option awards | $160,787 | $229,603 | $190,998 | $641,565 | $288,865 | $200,953 | $423,345 |
| Non-equity incentive | $160,000 | $180,000 | $200,000 | $0 | $345,728 | $450,000 | $750,000 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | — |
| All other | $55,977 | $8,100 | $8,250 | $9,150 | $9,900 | $10,350 | $10,500 |
| Total | $576,764 | $680,903 | $647,344 | $1,340,715 | $1,295,965 | $1,254,583 | $2,180,555 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: National Health Investors Inc. DEF 14A filed April 3, 2026, accession 0000877860-26-000098, and prior-year filings.
How this page was built: the National Health Investors Inc. filed document, accession 0000877860-26-000098. Every figure is read from that document and cited to the page and table it appears in. Filed April 3, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 11,300 | $862,981 | — |
| Option | 30,000 | — | $73.34 |
| Option | 8,500 | — | $57.76 |
Per the Outstanding Equity Awards at Fiscal Year-End table in National Health Investors Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed April 3, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-05 | Tax withholding | — | 314 | $73.09 | 56,286.64 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
National Health Investors’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| D. Eric Mendelsohn | President and CEO | $3,652,795 |
| John Spaid · this page | Executive Vice President of Finance, Chief Financial Officer and Treasurer | $2,180,555 |
| Kevin Pascoe | Executive Vice President of Investments and Chief Investment Officer | $1,987,215 |
| David Travis | Senior Vice President and Chief Accounting Officer | $1,438,600 |
| Kristin Gaines | Senior Vice President and Chief Transaction Officer | $1,326,552 |
John Spaid's compensation dossier, National Health Investors
You have read John Spaid's totals and holdings. The dossier adds each equity grant National Health Investors disclosed for John Spaid and National Health Investors's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full National Health Investors compensation record
free company briefThis page is one person within National Health Investors's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the National Health Investors proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order National Health Investors's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are National Health Investors's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.